Selected research
Industry Research
Intestinal Ascariasis Medicine Industry Research Report 2026
Market perspective
The global Intestinal Ascariasis Medicine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Intestinal Ascariasis Medicine market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Intestinal Ascariasis Medicine market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Intestinal Ascariasis Medicine market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Intestinal Ascariasis Medicine include Actavis, Bayer HealthCare, Bullvet, Cipla, Endo Pharmaceuticals, Henan Sino New Energy Material, Inject Care Parenterals, Purdue Pharma and Pfizer, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Intestinal Ascariasis Medicine market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Intestinal Ascariasis Medicine.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Intestinal Ascariasis Medicine Market by Company
Actavis
Bayer HealthCare
Bullvet
Cipla
Endo Pharmaceuticals
Henan Sino New Energy Material
Inject Care Parenterals
Purdue Pharma
Pfizer
Novartis
Johnson & Johnson
Sanofi
Sun Pharmaceutical Industries
Intestinal Ascariasis Medicine Segment by Type
Painkiller
Piperazine Citrate
Complication Treatment Drug
Others
Intestinal Ascariasis Medicine Segment by Application
Patients With Ulcer Disease
Complication Treatment
Others
Intestinal Ascariasis Medicine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intestinal Ascariasis Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Intestinal Ascariasis Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intestinal Ascariasis Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Intestinal Ascariasis Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Painkiller
- Piperazine Citrate
- Complication Treatment Drug
- Others
Applications
- Patients With Ulcer Disease
- Complication Treatment
- Others
Companies covered
- Actavis
- Bayer HealthCare
- Bullvet
- Cipla
- Endo Pharmaceuticals
- Henan Sino New Energy Material
- Inject Care Parenterals
- Purdue Pharma
- Pfizer
- Novartis
- Johnson & Johnson
- Sanofi
- Sun Pharmaceutical Industries
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Intestinal Ascariasis Medicine by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Painkiller
- 2.2.3 Piperazine Citrate
- 2.2.4 Complication Treatment Drug
- 2.2.5 Others
- 2.3 Intestinal Ascariasis Medicine by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Patients With Ulcer Disease
- 2.3.3 Complication Treatment
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Intestinal Ascariasis Medicine Breakdown Data by Type
- 3.1 Global Intestinal Ascariasis Medicine Historic Market Size by Type (2021-2026)
- 3.2 Global Intestinal Ascariasis Medicine Forecasted Market Size by Type (2027-2032)
4 Intestinal Ascariasis Medicine Breakdown Data by Application
- 4.1 Global Intestinal Ascariasis Medicine Historic Market Size by Application (2021-2026)
- 4.2 Global Intestinal Ascariasis Medicine Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Intestinal Ascariasis Medicine Market Perspective (2021-2032)
- 5.2 Global Intestinal Ascariasis Medicine Growth Trends by Region
- 5.2.1 Global Intestinal Ascariasis Medicine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Intestinal Ascariasis Medicine Historic Market Size by Region (2021-2026)
- 5.2.3 Intestinal Ascariasis Medicine Forecasted Market Size by Region (2027-2032)
- 5.3 Intestinal Ascariasis Medicine Market Dynamics
- 5.3.1 Intestinal Ascariasis Medicine Industry Trends
- 5.3.2 Intestinal Ascariasis Medicine Market Drivers
- 5.3.3 Intestinal Ascariasis Medicine Market Challenges
- 5.3.4 Intestinal Ascariasis Medicine Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Intestinal Ascariasis Medicine Players by Revenue
- 6.1.1 Global Top Intestinal Ascariasis Medicine Players by Revenue (2021-2026)
- 6.1.2 Global Intestinal Ascariasis Medicine Revenue Market Share by Players (2021-2026)
- 6.2 Global Intestinal Ascariasis Medicine Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Intestinal Ascariasis Medicine Head Office and Area Served
- 6.4 Global Intestinal Ascariasis Medicine Players, Product Type & Application
- 6.5 Global Intestinal Ascariasis Medicine Manufacturers Established Date
- 6.6 Global Intestinal Ascariasis Medicine Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Intestinal Ascariasis Medicine Market Size (2021-2032)
- 7.2 North America Intestinal Ascariasis Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Intestinal Ascariasis Medicine Market Size by Country (2021-2026)
- 7.4 North America Intestinal Ascariasis Medicine Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Intestinal Ascariasis Medicine Market Size (2021-2032)
- 8.2 Europe Intestinal Ascariasis Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Intestinal Ascariasis Medicine Market Size by Country (2021-2026)
- 8.4 Europe Intestinal Ascariasis Medicine Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Intestinal Ascariasis Medicine Market Size (2021-2032)
- 9.2 Asia-Pacific Intestinal Ascariasis Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Intestinal Ascariasis Medicine Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Intestinal Ascariasis Medicine Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Intestinal Ascariasis Medicine Market Size (2021-2032)
- 10.2 South America Intestinal Ascariasis Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Intestinal Ascariasis Medicine Market Size by Country (2021-2026)
- 10.4 South America Intestinal Ascariasis Medicine Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Intestinal Ascariasis Medicine Market Size (2021-2032)
- 11.2 Middle East & Africa Intestinal Ascariasis Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Intestinal Ascariasis Medicine Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Intestinal Ascariasis Medicine Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Actavis
- 12.1.1 Actavis Company Information
- 12.1.2 Actavis Business Overview
- 12.1.3 Actavis Revenue in Intestinal Ascariasis Medicine Business (2021-2026)
- 12.1.4 Actavis Intestinal Ascariasis Medicine Product Portfolio
- 12.1.5 Actavis Recent Developments
- 12.2 Bayer HealthCare
- 12.2.1 Bayer HealthCare Company Information
- 12.2.2 Bayer HealthCare Business Overview
- 12.2.3 Bayer HealthCare Revenue in Intestinal Ascariasis Medicine Business (2021-2026)
- 12.2.4 Bayer HealthCare Intestinal Ascariasis Medicine Product Portfolio
- 12.2.5 Bayer HealthCare Recent Developments
- 12.3 Bullvet
- 12.3.1 Bullvet Company Information
- 12.3.2 Bullvet Business Overview
- 12.3.3 Bullvet Revenue in Intestinal Ascariasis Medicine Business (2021-2026)
- 12.3.4 Bullvet Intestinal Ascariasis Medicine Product Portfolio
- 12.3.5 Bullvet Recent Developments
- 12.4 Cipla
- 12.4.1 Cipla Company Information
- 12.4.2 Cipla Business Overview
- 12.4.3 Cipla Revenue in Intestinal Ascariasis Medicine Business (2021-2026)
- 12.4.4 Cipla Intestinal Ascariasis Medicine Product Portfolio
- 12.4.5 Cipla Recent Developments
- 12.5 Endo Pharmaceuticals
- 12.5.1 Endo Pharmaceuticals Company Information
- 12.5.2 Endo Pharmaceuticals Business Overview
- 12.5.3 Endo Pharmaceuticals Revenue in Intestinal Ascariasis Medicine Business (2021-2026)
- 12.5.4 Endo Pharmaceuticals Intestinal Ascariasis Medicine Product Portfolio
- 12.5.5 Endo Pharmaceuticals Recent Developments
- 12.6 Henan Sino New Energy Material
- 12.6.1 Henan Sino New Energy Material Company Information
- 12.6.2 Henan Sino New Energy Material Business Overview
- 12.6.3 Henan Sino New Energy Material Revenue in Intestinal Ascariasis Medicine Business (2021-2026)
- 12.6.4 Henan Sino New Energy Material Intestinal Ascariasis Medicine Product Portfolio
- 12.6.5 Henan Sino New Energy Material Recent Developments
- 12.7 Inject Care Parenterals
- 12.7.1 Inject Care Parenterals Company Information
- 12.7.2 Inject Care Parenterals Business Overview
- 12.7.3 Inject Care Parenterals Revenue in Intestinal Ascariasis Medicine Business (2021-2026)
- 12.7.4 Inject Care Parenterals Intestinal Ascariasis Medicine Product Portfolio
- 12.7.5 Inject Care Parenterals Recent Developments
- 12.8 Purdue Pharma
- 12.8.1 Purdue Pharma Company Information
- 12.8.2 Purdue Pharma Business Overview
- 12.8.3 Purdue Pharma Revenue in Intestinal Ascariasis Medicine Business (2021-2026)
- 12.8.4 Purdue Pharma Intestinal Ascariasis Medicine Product Portfolio
- 12.8.5 Purdue Pharma Recent Developments
- 12.9 Pfizer
- 12.9.1 Pfizer Company Information
- 12.9.2 Pfizer Business Overview
- 12.9.3 Pfizer Revenue in Intestinal Ascariasis Medicine Business (2021-2026)
- 12.9.4 Pfizer Intestinal Ascariasis Medicine Product Portfolio
- 12.9.5 Pfizer Recent Developments
- 12.10 Novartis
- 12.10.1 Novartis Company Information
- 12.10.2 Novartis Business Overview
- 12.10.3 Novartis Revenue in Intestinal Ascariasis Medicine Business (2021-2026)
- 12.10.4 Novartis Intestinal Ascariasis Medicine Product Portfolio
- 12.10.5 Novartis Recent Developments
- 12.11 Johnson & Johnson
- 12.11.1 Johnson & Johnson Company Information
- 12.11.2 Johnson & Johnson Business Overview
- 12.11.3 Johnson & Johnson Revenue in Intestinal Ascariasis Medicine Business (2021-2026)
- 12.11.4 Johnson & Johnson Intestinal Ascariasis Medicine Product Portfolio
- 12.11.5 Johnson & Johnson Recent Developments
- 12.12 Sanofi
- 12.12.1 Sanofi Company Information
- 12.12.2 Sanofi Business Overview
- 12.12.3 Sanofi Revenue in Intestinal Ascariasis Medicine Business (2021-2026)
- 12.12.4 Sanofi Intestinal Ascariasis Medicine Product Portfolio
- 12.12.5 Sanofi Recent Developments
- 12.13 Sun Pharmaceutical Industries
- 12.13.1 Sun Pharmaceutical Industries Company Information
- 12.13.2 Sun Pharmaceutical Industries Business Overview
- 12.13.3 Sun Pharmaceutical Industries Revenue in Intestinal Ascariasis Medicine Business (2021-2026)
- 12.13.4 Sun Pharmaceutical Industries Intestinal Ascariasis Medicine Product Portfolio
- 12.13.5 Sun Pharmaceutical Industries Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst